These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer. Zhuang Z, Merino MJ, Chuaqui R, Liotta LA, Emmert-Buck MR. Cancer Res; 1995 Feb 01; 55(3):467-71. PubMed ID: 7834608 [Abstract] [Full Text] [Related]
5. Loss of heterozygosity on chromosome 11q13 in lobular lesions of the breast using tissue microdissection and polymerase chain reaction. Nayar R, Zhuang Z, Merino MJ, Silverberg SG. Hum Pathol; 1997 Mar 01; 28(3):277-82. PubMed ID: 9042790 [Abstract] [Full Text] [Related]
7. Chromosomal alterations associated with the transition from in situ to invasive breast cancer. Ellsworth RE, Vertrees A, Love B, Hooke JA, Ellsworth DL, Shriver CD. Ann Surg Oncol; 2008 Sep 01; 15(9):2519-25. PubMed ID: 18622645 [Abstract] [Full Text] [Related]
8. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study. Ottesen GL. APMIS Suppl; 2003 Sep 01; (108):1-67. PubMed ID: 12874968 [Abstract] [Full Text] [Related]
14. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma. Castro NP, Osório CA, Torres C, Bastos EP, Mourão-Neto M, Soares FA, Brentani HP, Carraro DM. Breast Cancer Res; 2008 Sep 01; 10(5):R87. PubMed ID: 18928525 [Abstract] [Full Text] [Related]